{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:17:54Z","timestamp":1785554274815,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03363-x","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:45:17Z","timestamp":1759491917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GLUT and FAP\u03b1 as molecular markers for interstitial lung disease in systemic sclerosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Bo","family":"Broens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny J.","family":"van der Laken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Radonic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther J.","family":"Nossent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue D.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehya","family":"Al-Adwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Tji","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Timens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre E.","family":"Voskuyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Duitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"10103","key":"3363_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685\u201399.","journal-title":"Lancet"},{"issue":"3","key":"3363_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respiratory Med. 2020;8(3):304\u201320.","journal-title":"Lancet Respiratory Med"},{"issue":"2","key":"3363_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","volume":"80","author":"A-M Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold A-M, Allanore Y, Alves M, Brunborg C, Air\u00f3 P, Ananieva LP, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis. 2021;80(2):219\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3363_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/ard.2008.091710","volume":"68","author":"MC Vonk","year":"2009","unstructured":"Vonk MC, Broers B, Heijdra YF, Ton E, Snijder R, van Dijk AP, et al. Systemic sclerosis and its pulmonary complications in the netherlands: an epidemiological study. Ann Rheum Dis. 2009;68(6):961\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3363_CR5","doi-asserted-by":"publisher","first-page":"102978","DOI":"10.1016\/j.autrev.2021.102978","volume":"20","author":"MC Vonk","year":"2021","unstructured":"Vonk MC, Smith V, Sfikakis PP, Cutolo M, del Galdo F, Seibold JR. Pharmacological treatments for SSc-ILD: systematic review and critical appraisal of the evidence. Autoimmun Rev. 2021;20(12):102978.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"3363_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NSL Goh","year":"2008","unstructured":"Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis. Am J Respir Crit Care Med. 2008;177(11):1248\u201354.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3363_CR7","first-page":"121","volume":"19","author":"DS Kim","year":"2002","unstructured":"Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):121\u20137.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"3363_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1378\/chest.08-0053","volume":"134","author":"A Fischer","year":"2008","unstructured":"Fischer A, Swigris JJ, Groshong SD, Cool CD, Sahin H, Lynch DA, et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest. 2008;134(3):601\u20135.","journal-title":"Chest"},{"issue":"2","key":"3363_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.2322031223","volume":"232","author":"SR Desai","year":"2004","unstructured":"Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232(2):560\u20137.","journal-title":"Radiology"},{"issue":"3","key":"3363_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/BOR.0000000000000270","volume":"28","author":"B Wallace","year":"2016","unstructured":"Wallace B, Vummidi D, Khanna D. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature. Curr Opin Rheumatol. 2016;28(3):236\u201345.","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 5","key":"3363_CR11","doi-asserted-by":"publisher","first-page":"v59","DOI":"10.1093\/rheumatology\/ken271","volume":"47","author":"AU Wells","year":"2008","unstructured":"Wells AU. High-resolution computed tomography and scleroderma lung disease. Rheumatology (Oxford). 2008;47(Suppl 5):v59\u201361.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3363_CR12","doi-asserted-by":"publisher","first-page":"1902026","DOI":"10.1183\/13993003.02026-2019","volume":"55","author":"O Distler","year":"2020","unstructured":"Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020;55(5):1902026.","journal-title":"Eur Respir J"},{"issue":"5","key":"3363_CR13","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1183\/13993003.01633-2016","volume":"48","author":"V Cottin","year":"2016","unstructured":"Cottin V. Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty. Eur Respir J. 2016;48(5):1274.","journal-title":"Eur Respir J"},{"key":"3363_CR14","doi-asserted-by":"crossref","unstructured":"Broens B, van der Laken CJ, Zwezerijnen GJC, Nossent EJ, Meijboom LJ, Spierings J et al. Positron emission tomography to improve assessment of interstitial lung disease in patients with systemic sclerosis eligible for autologous stem cell transplantation. Front Immunol. 2022;13:923869.","DOI":"10.3389\/fimmu.2022.923869"},{"issue":"3","key":"3363_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cpet.2016.02.008","volume":"11","author":"S Hess","year":"2016","unstructured":"Hess S, Alavi A, Basu S. PET-Based personalized management of infectious and inflammatory disorders. PET Clin. 2016;11(3):351\u201361.","journal-title":"PET Clin"},{"issue":"7","key":"3363_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck J, Sonanini D, Cotton JM, Rammensee H-G, la Foug\u00e8re C, Zender L, et al. Advances in PET imaging of cancer. Nat Rev Cancer. 2023;23(7):474\u201390.","journal-title":"Nat Rev Cancer"},{"issue":"48","key":"3363_CR17","doi-asserted-by":"publisher","first-page":"e5462","DOI":"10.1097\/MD.0000000000005462","volume":"95","author":"ZG Wang","year":"2016","unstructured":"Wang ZG, Yu MM, Han Y, Wu FY, Yang GJ, Li DC, et al. Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions. Medicine. 2016;95(48):e5462.","journal-title":"Medicine"},{"issue":"6","key":"3363_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1378\/chest.12-1359","volume":"143","author":"S El-Chemaly","year":"2013","unstructured":"El-Chemaly S, Malide D, Yao J, Nathan SD, Rosas IO, Gahl WA, et al. Glucose transporter-1 distribution in fibrotic lung disease: association with [\u00b9\u2078F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization. Chest. 2013;143(6):1685\u201391.","journal-title":"Chest"},{"issue":"1","key":"3363_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13075-021-02460-8","volume":"23","author":"E Ledoult","year":"2021","unstructured":"Ledoult E, Morelle M, Soussan M, M\u00e9kinian A, B\u00e9hal H, Sobanski V, et al. (18)F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study. Arthritis Res Ther. 2021;23(1):76.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"3363_CR20","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.ejrad.2016.10.001","volume":"85","author":"V Jacquelin","year":"2016","unstructured":"Jacquelin V, Mekinian A, Brillet PY, Nunes H, Fain O, Valeyre D, et al. FDG-PET\/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A pilot study. Eur J Radiol. 2016;85(12):2200\u20135.","journal-title":"Eur J Radiol"},{"issue":"1","key":"3363_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-017-0556-3","volume":"18","author":"A Justet","year":"2017","unstructured":"Justet A, Laurent-Bellue A, Thabut G, Dieudonn\u00e9 A, Debray MP, Borie R, et al. [(18)F]FDG PET\/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis. Respir Res. 2017;18(1):74.","journal-title":"Respir Res"},{"issue":"6","key":"3363_CR22","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/rheumatology\/kez483","volume":"59","author":"DM Peelen","year":"2020","unstructured":"Peelen DM, Zwezerijnen BGJC, Nossent EJ, Meijboom LJ, Hoekstra OS, Van der Laken CJ, et al. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients. Rheumatology. 2020;59(6):1407\u201315.","journal-title":"Rheumatology"},{"issue":"1","key":"3363_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-024-03447-x","volume":"26","author":"B Broens","year":"2024","unstructured":"Broens B, Nossent EJ, Meijboom LJ, Zwezerijnen GJ, Spierings J, de Vries-Bouwstra JK, et al. Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis. Arthritis Res Therapy. 2024;26(1):219.","journal-title":"Arthritis Res Therapy"},{"issue":"3","key":"3363_CR24","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","volume":"3","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, Distler JHW, Treutlein C, Tascilar K, M\u00fcller A-T, Atzinger A, et al. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. Lancet Rheumatol. 2021;3(3):e185\u201394.","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"3363_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"3363_CR26","doi-asserted-by":"publisher","first-page":"103297","DOI":"10.1016\/j.jaut.2024.103297","volume":"148","author":"Y Al-Adwi","year":"2024","unstructured":"Al-Adwi Y, Westra J, van Goor H, van Kempen LC, Osman M, Gan CT, et al. Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD). J Autoimmun. 2024;148:103297.","journal-title":"J Autoimmun"},{"issue":"3","key":"3363_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","volume":"37","author":"PS Acharya","year":"2006","unstructured":"Acharya PS, Zukas A, Chandan V, Katzenstein AL, Pur\u00e9 E. Fibroblast activation protein: a Serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol. 2006;37(3):352\u201360.","journal-title":"Hum Pathol"},{"issue":"2","key":"3363_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","volume":"207","author":"P Yang","year":"2023","unstructured":"Yang P, Luo Q, Wang X, Fang Q, Fu Z, Li J, et al. Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases. Am J Respir Crit Care Med. 2023;207(2):160\u201372.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3363_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/ph17060726","volume":"17","author":"H Ji","year":"2024","unstructured":"Ji H, Song X, Lv X, Shao F, Long Y, Song Y, et al. [68Ga]FAPI PET for imaging and treatment monitoring in a preclinical model of pulmonary fibrosis: comparison to [18F]FDG PET and CT. Pharmaceuticals. 2024;17(6):726.","journal-title":"Pharmaceuticals"},{"key":"3363_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nucmedbio.2017.01.005","volume":"48","author":"RS Rodrigues","year":"2017","unstructured":"Rodrigues RS, Bozza FA, Hanrahan CJ, Wang L-M, Wu Q, Hoffman JM, et al. 18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury. Nucl Med Biol. 2017;48:52\u201362.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"3363_CR31","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1152\/ajpendo.90388.2008","volume":"295","author":"IA Simpson","year":"2008","unstructured":"Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiology-Endocrinology Metabolism. 2008;295(2):E242\u201353.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"4","key":"3363_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00408-004-2542-z","volume":"183","author":"ER Parra","year":"2005","unstructured":"Parra ER, David YR, Costa LRSd, Ab\u2019Saber A, Sousa R, Kairalla RA, et al. Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis. Lung. 2005;183(4):291\u2013300.","journal-title":"Lung"},{"issue":"6","key":"3363_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1513\/pats.201101-007MW","volume":"8","author":"L Farkas","year":"2011","unstructured":"Farkas L, Kolb M. Pulmonary microcirculation in interstitial lung disease. Proc Am Thorac Soc. 2011;8(6):516\u201321.","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"3363_CR34","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.21037\/qims-24-1770","volume":"15","author":"R Li","year":"2025","unstructured":"Li R, Liu S, Wang X, Wang R. Assessing pulmonary vascular remodeling in connective tissue disease-associated interstitial lung disease: a CT-based quantitative analysis. Quant Imaging Med Surg. 2025;15(4):3333\u201346.","journal-title":"Quant Imaging Med Surg"},{"key":"3363_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1755-8794-4-70","volume":"4","author":"EB Meltzer","year":"2011","unstructured":"Meltzer EB, Barry WT, D\u2019Amico TA, Davis RD, Lin SS, Onaitis MW, et al. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics. 2011;4:70.","journal-title":"BMC Med Genomics"},{"issue":"4","key":"3363_CR36","doi-asserted-by":"publisher","first-page":"e59348","DOI":"10.1371\/journal.pone.0059348","volume":"8","author":"R Peng","year":"2013","unstructured":"Peng R, Sridhar S, Tyagi G, Phillips JE, Garrido R, Harris P, et al. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for active disease. PLoS ONE. 2013;8(4):e59348.","journal-title":"PLoS ONE"},{"issue":"12","key":"3363_CR37","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1096\/fj.201600373R","volume":"30","author":"X Peng","year":"2016","unstructured":"Peng X, Moore M, Mathur A, Zhou Y, Sun H, Gan Y, et al. Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis. FASEB J. 2016;30(12):4056\u201370.","journal-title":"FASEB J"},{"issue":"3","key":"3363_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803.","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"3363_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","volume":"199","author":"PA Reyfman","year":"2019","unstructured":"Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S, et al. Single-Cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(12):1517\u201336.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3363_CR40","doi-asserted-by":"publisher","first-page":"L271","DOI":"10.1152\/ajplung.00071.2019","volume":"317","author":"T Kimura","year":"2019","unstructured":"Kimura T, Monslow J, Klampatsa A, Leibowitz M, Sun J, Liousia M, et al. Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-\u03b2 and chronic bleomycin-induced fibrosis. Am J Physiol Lung Cell Mol Physiol. 2019;317(2):L271\u201382.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"15","key":"3363_CR41","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1074\/jbc.M115.701433","volume":"291","author":"MH Fan","year":"2016","unstructured":"Fan MH, Zhu Q, Li HH, Ra HJ, Majumdar S, Gulick DL, et al. Fibroblast activation protein (FAP) accelerates collagen degradation and clearance from lungs in mice. J Biol Chem. 2016;291(15):8070\u201389.","journal-title":"J Biol Chem"},{"key":"3363_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","volume":"809","author":"C Egger","year":"2017","unstructured":"Egger C, Cannet C, G\u00e9rard C, Suply T, Ksiazek I, Jarman E, et al. Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis. Eur J Pharmacol. 2017;809:64\u201372.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3363_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2967\/jnumed.120.244723","volume":"62","author":"Y Luo","year":"2021","unstructured":"Luo Y, Pan Q, Yang H, Peng L, Zhang W, Li F. Fibroblast activation Protein\u2013Targeted PET\/CT with 68Ga-FAPI for imaging IgG4-Related disease: comparison to <\u2009sup\u2009>\u200918\u2009F-FDG PET\/CT. J Nucl Med. 2021;62(2):266\u201371.","journal-title":"J Nucl Med"},{"issue":"11","key":"3363_CR44","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","volume":"79","author":"C Schmidkonz","year":"2020","unstructured":"Schmidkonz C, Rauber S, Atzinger A, Agarwal R, G\u00f6tz TI, Soare A, et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020;79(11):1485.","journal-title":"Ann Rheum Dis"},{"key":"3363_CR45","doi-asserted-by":"crossref","unstructured":"Hotta M, Kim GHJ, Rerkpichaisuth V, Teng PY, Armstrong WR, Carlucci G et al. Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease. J Nucl Med. 2024:jnumed.124.268351.","DOI":"10.2967\/jnumed.124.268351"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03363-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03363-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03363-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:03:38Z","timestamp":1759496618000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03363-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3363"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03363-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committees and the scientific committees of the pathology biobank of the Amsterdam UMC (2021.0436) and UMCG Groningen (2019.00015). All patients, or their legal representatives in autopsy cases, provided both oral and written consent for the use of their data and lung tissue. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}